Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
IC50 Assay from US Patent US11890356: "HDAC6 inhibitors and imaging agents"
Assay data:18 Active, 16 Activity ≤ 1 µM, 18 Tested
SummaryRelated BioAssays by Target
Inhibition of human recombinant HDAC6 assessed as residual activity at 2 uM relative to control
Assay data:6 Tested
Inhibition of human recombinant HDAC6 assessed as residual activity at 20 uM relative to control
Assay data:14 Tested
Inhibition of HDAC in human HeLa nuclear extract assessed as residual activity at 20 uM relative to control
Assay data:16 Tested
Inhibition of HDAC in human HCT-116 cells assessed as increase in alpha tubulin acetylation at 1 uM incubated for 24 hrs by Western blot analysis
Assay data:1 Active, 1 Tested
Inhibition of HDAC in human HCT-116 cells assessed as increase in histone H3 acetylation at 1 uM incubated for 24 hrs by Western blot analysis
Inhibition of HDAC in human HCT-116 cells assessed as increase in alpha tubulin acetylation incubated for 24 hrs by Western blot analysis
Assay data:1 Tested
Inhibition of HDAC in human HCT-116 cells assessed as increase in histone H3 acetylation incubated for 24 hrs by Western blot analysis
Inhibition of HDAC6 (unknown origin)
Assay data:2 Active, 2 Activity ≤ 1 µM, 2 Tested
Inhibition of HDAC in human HeLa nuclear extract at 0.1 uM using Boc-Lys(Ac)-AMC or Boc-Lys(Tfa)-AMC as substrate preincubated for 5 mins followed by substrate addition and measured after 30 mins by fluorescence assay
Assay data:9 Tested
Inhibition of HDAC6 (unknown origin) using Boc-Lys(Ac)-AMC or Boc-Lys(Tfa)-AMC as substrate preincubated for 5 mins followed by substrate addition and measured after 2 hrs by fluorescence assay
Assay data:5 Active, 5 Activity ≤ 1 µM, 5 Tested
Inhibition of HDAC in human HeLa nuclear extract using Boc-Lys(Ac)-AMC or Boc-Lys(Tfa)-AMC as substrate preincubated for 5 mins followed by substrate addition and measured after 30 mins by fluorescence assay
Assay data:11 Active, 11 Activity ≤ 1 µM, 11 Tested
Inhibition of HDAC in human HeLa nuclear extract at 0.1 uM using Boc-Lys(Ac)-AMC or Boc-Lys(Tfa)-AMC as substrate preincubated for 5 mins followed by substrate addition and measured after 30 mins by fluorescence assay relative to control
Assay data:30 Tested
Inhibition of HDAC in human HepG2 cells assessed as increase in histone H3 acetylation at 5 uM incubated for 24 hrs by Western blot analysis
Inhibition of HDAC in human Huh-7 cells assessed as increase in histone H3 acetylation at 5 uM incubated for 24 hrs by Western blot analysis
Inhibition of HDAC in human HepG2 cells assessed as increase in histone H3 acetylation at 20 uM incubated for 24 hrs by Western blot analysis
Assay data:1 Active, 2 Tested
Inhibition of HDAC in human Huh-7 cells assessed as increase in histone H3 acetylation at 20 uM incubated for 24 hrs by Western blot analysis
Inhibition of HDAC in human HepG2 cells assessed as increase in histone H3 acetylation at 20 to 40 uM incubated for 24 hrs by Western blot analysis
Inhibition of HDAC in human Huh-7 cells assessed as increase in histone H3 acetylation at 20 to 40 uM incubated for 24 hrs by Western blot analysis
Inhibition of HDAC in human HeLa cell extracts using Boc-Lys(Ac)-AM as substrate by fluorescence based analysis
Assay data:3 Active, 3 Activity ≤ 1 µM, 5 Tested
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on